| Descriptor English: | Carbonyl Reductase (NADPH) | ||||||
| Descriptor Spanish: |
Carbonil Reductasa (NADPH)
| ||||||
| Descriptor Portuguese: | Carbonil Redutase (NADPH) | ||||||
| Descriptor French: | NADPH-carbonyl reductase | ||||||
| Entry term(s): |
13,14 dihydroprostaglandin F2 alpha Synthetase 13,14 dihydroprostaglandin F2alpha Synthetase 13,14-dihydroprostaglandin F2 alpha Synthetase 13,14-dihydroprostaglandin F2alpha Synthetase Carbonyl Reductase 1 Carbonyl Reductase, NADPH-dependent Carbonyl Reductase, Ovarian Daunorubicin Reductase Dehydrogenase-Reductase, Monomeric Short-Chain Isatin Reductase Monomeric Short Chain Dehydrogenase Reductase Monomeric Short-Chain Dehydrogenase-Reductase NADPH Carbonyl Reductase NADPH dependent Carbonyl Reductase NADPH-Carbonyl Reductase NADPH-dependent Carbonyl Reductase Ovarian Carbonyl Reductase Reductase, Daunorubicin Reductase, Isatin Reductase, NADPH-Carbonyl Reductase, NADPH-dependent Carbonyl Reductase, Ovarian Carbonyl Short-Chain Dehydrogenase-Reductase, Monomeric Synthetase, 13,14-dihydroprostaglandin F2alpha |
||||||
| Tree number(s): |
D08.811.682.047.820.289 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000074409 | ||||||
| Scope note: | NADPH-dependent reductase that catalyzes the reduction of many carbonyl compounds including QUINONES; PROSTAGLANDINS; and XENOBIOTICS. |
||||||
| Allowable Qualifiers: |
AD administration & dosage AE adverse effects AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
| Registry Number: | EC 1.1.1.184 | ||||||
| Public MeSH Note: | 2018; CARBONYL REDUCTASE (NADPH) was indexed under ALDEHYDE REDUCTASE 1975-2017 |
||||||
| History Note: | 2018 (1974) |
||||||
| DeCS ID: | 57019 | ||||||
| Unique ID: | D000074409 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 2018/01/01 | ||||||
| Date of Entry: | 2017/07/11 | ||||||
| Revision Date: | 2017/04/05 |
-
-
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes
|
|
Carbonyl Reductase (NADPH)
- Preferred
| Concept UI |
M0147200 |
| Scope note | NADPH-dependent reductase that catalyzes the reduction of many carbonyl compounds including QUINONES; PROSTAGLANDINS; and XENOBIOTICS. |
| Preferred term | Carbonyl Reductase (NADPH) |
| Entry term(s) |
13,14 dihydroprostaglandin F2 alpha Synthetase 13,14 dihydroprostaglandin F2alpha Synthetase 13,14-dihydroprostaglandin F2 alpha Synthetase 13,14-dihydroprostaglandin F2alpha Synthetase Carbonyl Reductase 1 Carbonyl Reductase, NADPH-dependent Carbonyl Reductase, Ovarian Daunorubicin Reductase Dehydrogenase-Reductase, Monomeric Short-Chain Isatin Reductase Monomeric Short Chain Dehydrogenase Reductase Monomeric Short-Chain Dehydrogenase-Reductase NADPH Carbonyl Reductase NADPH dependent Carbonyl Reductase NADPH-Carbonyl Reductase NADPH-dependent Carbonyl Reductase Ovarian Carbonyl Reductase Reductase, Daunorubicin Reductase, Isatin Reductase, NADPH-Carbonyl Reductase, NADPH-dependent Carbonyl Reductase, Ovarian Carbonyl Short-Chain Dehydrogenase-Reductase, Monomeric Synthetase, 13,14-dihydroprostaglandin F2alpha |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
